In the CNS, dysregulation of NCX has been implicated in several neurodegenerative diseases and conditions such as Alzheimer’s disease, Parkinson’s disease, and post-ischemic brain injury [1,2,3,4]. This evidence concerns the gene TLX2 and early-onset autosomal dominant Alzheimer disease.